These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 221854)

  • 1. Neuromuscular defect after suppression of ion conductance.
    Takamori M; Ide Y; Kasai M
    Neurology; 1979 Jun; 29(6):772-9. PubMed ID: 221854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non-immunogenic myasthenia gravis model and its application in a study of transsynaptic regulation at the neuromuscular junction.
    Molenaar PC; Oen BS; Plomp JJ; Van Kempen GT; Jennekens FG; Hesselmans LF
    Eur J Pharmacol; 1991 Apr; 196(1):93-101. PubMed ID: 1874282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro.
    Burges J; Wray DW; Pizzighella S; Hall Z; Vincent A
    Muscle Nerve; 1990 May; 13(5):407-13. PubMed ID: 2345558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presynaptic function modified by acetylcholine-receptor interaction in experimental autoimmune myasthenia gravis.
    Takamori M; Sakato S; Okumura S
    J Neurol Sci; 1984; 66(2-3):245-53. PubMed ID: 6099402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular transmission in neonatal mice injected with serum globulin of myasthenia gravis patients.
    Pagala MK; Tada S; Namba T; Grob D
    Neurology; 1982 Jan; 32(1):12-7. PubMed ID: 6275304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apparent lack of effect on alpha-bungarotoxin on the spike-induced release of acetylcholine at the mammalian motor end-plate.
    Gelsema AJ
    Neurosci Lett; 1980 Nov; 20(2):189-93. PubMed ID: 7443068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Run-down of neuromuscular transmission during repetitive nerve activity by nicotinic antagonists is not due to desensitization of the postsynaptic receptor.
    Hong SJ; Chang CC
    Br J Pharmacol; 1991 Apr; 102(4):817-22. PubMed ID: 1677297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental myasthenia due to alpha-bungarotoxin.
    Takamori M; Iwanaga S
    Neurology; 1976 Sep; 26(9):844-8. PubMed ID: 181695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylcholine release in diaphragm of rats with chronic experimental autoimmune myasthenia gravis.
    Kelly JJ; Lambert EH; Lennon VA
    Ann Neurol; 1978 Jul; 4(1):67-72. PubMed ID: 211931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The site and mode of action of propanidid on the peripheral motor unit.
    Ellis FR
    Anaesthesist; 1971 Jan; 20(1):19-22. PubMed ID: 4322995
    [No Abstract]   [Full Text] [Related]  

  • 11. Ephedrine: effects on neuromuscular transmission.
    Sieb JP; Engel AG
    Brain Res; 1993 Sep; 623(1):167-71. PubMed ID: 8221087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor nerve sprouting and acetylcholine receptors.
    Pestronk A; Drachman DB
    Science; 1978 Mar; 199(4334):1223-5. PubMed ID: 204007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptides isolated from the venom of Conus geographus block neuromuscular transmission.
    McManus OB; Musick JR; Gonzalez C
    Neurosci Lett; 1981 Aug; 25(1):57-62. PubMed ID: 6269031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylcholine receptor and ion conductance modulator sites at the murine neuromuscular junction: evidence from specific toxin reactions.
    Albuquerque EX; Barnard EA; Chiu TH; Lapa AJ; Dolly JO; Jansson SE; Daly J; Witkop B
    Proc Natl Acad Sci U S A; 1973 Mar; 70(3):949-53. PubMed ID: 4351811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further evidence that extrinsic acetylcholine acts preferentially on extrajunctional receptors in the chick biventer cervicis muscle.
    Chang CC; Su MJ
    Eur J Pharmacol; 1975; 33(2):337-44. PubMed ID: 1237410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis of the mechanisms underlying the non-quantal release of acetylcholine at the mouse neuromuscular junction.
    Vyskocil F; Nikolsky E; Edwards C
    Neuroscience; 1983 Jun; 9(2):429-35. PubMed ID: 6308511
    [No Abstract]   [Full Text] [Related]  

  • 17. The neuromuscular junction: recent developments.
    Bowman WC
    Eur J Anaesthesiol; 1985 Mar; 2(1):59-93. PubMed ID: 2410263
    [No Abstract]   [Full Text] [Related]  

  • 18. The upregulation of acetylcholine release at endplates of alpha-bungarotoxin-treated rats: its dependency on calcium.
    Plomp JJ; van Kempen GT; Molenaar PC
    J Physiol; 1994 Jul; 478 ( Pt 1)(Pt 1):125-36. PubMed ID: 7965828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylcholine receptor availability and transmission efficacy.
    Rochel S; Robbins N
    Brain Res; 1987 Dec; 435(1-2):41-7. PubMed ID: 2827857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
    Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
    J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.